Published by Alexander Bueso on 9th December 2019
(Sharecast News) - Open Orphan, the rare and orphan drug services company, has agreed the takeover of hVIVO by means of an all-share reverse take-over at a 33.8% premium.
URL: http://www.digitallook.com/dl/news/story/29969971/...